Browsing Category
Pharma Industry News
4730 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Saphnelo self-injection authorized in EU: AstraZeneca expands delivery options for lupus
Find out how AstraZeneca’s self-injection approval for Saphnelo could expand lupus treatment access and reshape biologic therapy delivery in Europe.
Can Norgine turn Vir Biotechnology’s hepatitis D duo into a regional blockbuster? €550m deal signals big bet
Vir Biotechnology licenses its hepatitis D therapy to Norgine in a €550M deal. Find out what this means for commercialization, access, and biotech strategy.
Can OrsoBio’s TLC-6740 combination data reopen the race for post-GLP obesity differentiation?
OrsoBio’s TLC-6740 combo data hints at a new way to extend GLP-1 weight loss without higher doses. Read what this means for obesity drug development.
How Cosette Pharmaceuticals used CGT exclusivity to unlock a long-ignored ear infection drug market
Cosette Pharmaceuticals secures FDA approval with CGT exclusivity for a long-protected otic drug. Read what this signals for specialty generics.
BlueWind Medical secures FDA clearance for enhanced Revi wearable as neuromodulation adoption shifts
BlueWind Medical secures FDA clearance for an enhanced Revi wearable. Find out why adherence, not efficacy, is shaping neuromodulation strategy.
I-SPY 2 data puts Natera’s Signatera at the center of early breast cancer risk debates
Natera’s I-SPY 2 data suggests ctDNA may finally align early breast cancer risk with treatment intensity. Read why this matters for payers and markets.
Sanofi invests up to $1bn in South Korean biotech ADEL to advance tau-based Alzheimer’s therapy
Sanofi has signed an up to $1 billion Alzheimer’s drug deal with South Korean biotech ADEL. Find out what the tau targeting strategy means for investors and patients.
What May Health’s CE Mark approval reveals about unmet demand in PCOS infertility care
May Health’s Anavi System wins CE Mark. Discover what this means for fertility clinics, PCOS care pathways, and women’s health innovation in Europe.
FDA nod sends Organogenesis shares higher as ReNu eyes BLA filing for knee osteoarthritis pain
Find out how Organogenesis’ FDA alignment clears the path for a ReNu BLA filing in knee osteoarthritis pain and why investors are paying attention now.
FDA clears Amphastar Pharmaceuticals’ teriparatide injection, opening a new growth pathway in osteoporosis treatment
Find out how FDA approval of Amphastar Pharmaceuticals’ teriparatide injection opens a new growth pathway in the U.S. osteoporosis treatment market.